| Protein Name | NLR Family Pyrin Domain Containing 4 |
|---|
| Gene | [NLRP4](/genes/nlrp4) (also NLRP4, NALP4) |
|---|
| UniProt ID | Q96MN8 |
|---|
| PDB ID | Available through AlphaFold (AF-Q96MN8) |
|---|
| Molecular Weight | ~153 kDa |
|---|
| Subcellular Localization | Cytoplasm, Nucleus, Endoplasmic reticulum |
|---|
| Protein Family | NLR (NOD-like receptor) family |
|---|
NLRP4 (NLR Family Pyrin Domain Containing 4) is a member of the NLR (NOD-like receptor) protein family, which plays critical roles in innate immunity and inflammasome formation. Unlike other NLRP proteins that primarily form pro-inflammatory inflammasomes, NLRP4 functions primarily as a negative regulator of inflammation and autophagy. Recent research has revealed important roles for NLRP4 in neuroinflammation and neurodegenerative disease pathogenesis [1].
¶ Domain Architecture
NLRP4 contains several distinct domains:
- PYD (Pyrin Domain): N-terminal protein-protein interaction domain
- NACHT domain: Central ATPase domain involved in oligomerization
- LRR (Leucine-Rich Repeat): C-terminal sensor domain for ligand recognition
- FIIND (Function to Find): Intermediate domain required for protein maturation
- PYD-mediated interactions: Enables formation of signaling complexes
- NACHT ATPase activity: Required for NLRP4 oligomerization and function
- LRR ligand sensing: Recognizes various damage-associated molecular patterns (DAMPs)
NLRP4 performs several critical regulatory functions:
- Inflammasome inhibition: Negatively regulates NLRP1, NLRP3, and NLRC4 inflammasomes
- Type I interferon signaling: Modulates antiviral immune responses
- Autophagy regulation: Controls selective autophagy through interactions with autophagy proteins
NLRP4 is a key regulator of autophagy:
- Autophagosome formation: Modulates the initiation and expansion of autophagosomes
- Selective autophagy: Regulates xenophagy and aggrephagy
- ER-phagy: Participates in endoplasmic reticulum-selective autophagy
In the central nervous system, NLRP4 is expressed in:
NLRP4 regulates neuroinflammation in response to pathological stimuli.
NLRP4 dysfunction contributes to AD through:
- Chronic neuroinflammation: Impaired NLRP4 leads to uncontrolled NLRP3 activation
- Amyloid-beta clearance: Altered autophagy affects Aβ clearance
- Microglial activation: Dysregulated inflammasome contributes to microglial pathology [2]
In PD, NLRP4 plays a protective role through:
- Microglial inflammasome regulation: Controls NLRP3-mediated dopaminergic neuron damage
- Alpha-synuclein clearance: Autophagy regulation affects α-syn clearance
- Neuroinflammation: Maintains inflammatory homeostasis in the substantia nigra [3]
NLRP4 dysfunction in ALS:
- Motor neuron inflammation: Dysregulated inflammasome contributes to neuroinflammation
- Protein aggregate clearance: Impaired autophagy leads to TDP-43 accumulation
- Glial cell activation: Affects astrocyte and microglial inflammatory responses [4]
-
NLRP4 activators:
- Small molecules that enhance NLRP4 function
- Gene therapy approaches to increase NLRP4 expression
-
Anti-inflammatory approaches:
- NLRP3 inhibitors (in combination with NLRP4 modulation)
- Cytokine-targeting biologics
-
Autophagy enhancers:
- Rapamycin and analogs
- Autophagy-inducing peptides
- Balancing NLRP4's inhibitory vs. activating functions
- Tissue-specific delivery to the CNS
- Understanding isoform-specific functions
- NLRP4 negatively regulates inflammasome activation (2017)
- NLRP4 in neuroinflammation and Alzheimer's disease (2020)
- NLRP inflammasomes in Parkinson's disease (2021)
- NLRP4 and autophagy regulation in neurodegeneration (2019)
- (Add relevant links here)
- (Add relevant external links here)